Nurse Practitioner
CurrentRheumatology care for adult patients across the age spectrum from age 17 through end of lifeOsteoporosis management including interpretation of DXA studies, vertebral fracture analysis and trabecular bone scoring with management of anabolic and antiresorptive medications.Research ExperienceSub-Investigator● Ampel BioSolutions – AMP-005: An Open Label Multicenter Study to Assess the Relationship Between Data Obtained with the LuGENE Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients with Systemic Lupus Erythematosus (SLE) ● Scipher – PREDICT-102: Predict Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)Joint Evaluator● Setpoint – SPM-020: Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study ● Sanofi – DRI17821: A study to evaluate SAR441566 efficacy and safety in adults with rheumatoid arthritis● Immunovant – IVMT-1402-260: A Phase 2b, Multicenter, Double-blind, Placebo-controlled Randomized Withdrawal Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants with Active, Difficult-to-treat, ACPA-Positive Rheumatoid Arthritis● Horizon – HZNP-DAZ-301: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity